Tuesday, September 15, 2009

126:


The number of people who die in an hour from Heart Disease & Stroke.  

Monday, September 14, 2009

Untold Stories of the Heart

One woman dies almost every minute from heart disease. Yet studies show that only 21% of women view heart disease as their greatest health threat. The TV special, Untold Stories of the Heart, which premiered in 2008 and featured Marie Osmond, hosted by Hoda Kotb, raises awareness through the personal stories of women living with heart disease. Because for every heart there is a story, and these stories are at the heart of Go Red.
(above from the American Heart Association/Go Red For Women)

I've Been Wearing My Seat Belt All Along Thanks to My Cardiologist!

I have been extremely happy with the cardiologist who saved my life and continues to see me as a patient (insert big happy smile HERE!). Over time, I have realized that "my" cardiologist keeps very up to date with all things heart related. So it is no surprise to me to read the article below. A statin prescription has been in my daily regimen post heart attack. At first I was confused by the need for cholesterol prescription because I knew the lab results taken by the emergency room determine all of my cholesterol levels to be "good". My cardiologist explained that the statin was being prescribed because it was shown to help heal the heart (given that I had 10% damage/die off of my heart during my heart attack).

Regretfully, I have visited many doctors for various reasons and found advocacy to be a quality found few and far between. No fault of the doctor; I can't begin to imagine the amount of patients they see and the ongoing problems with insurance companies. So, three cheers for my awesome doctor being not only a phenomenal doctor/surgeon, but also an advocate for his patients!!!

Another doctor I see has recently suggested a vitamin supplement since I am taking a statin. I'll share why and what in the future.


Inexpensive drug that lowers cholesterol also decreases risk of dying
The Associated Press
updated 7:48 a.m. PT, Thurs., Sept . 3, 2009
NEW YORK - Score another victory for the cheap, cholesterol-lowering wonder drugs known as statins. People getting an artery unclogged or repaired were much less likely to die or have a heart attack afterward if they took preventive doses of the pills before and after their operations, a Dutch study showed.
Patients given Lescol had half the risk of having a heart attack or dying of a heart problem in the following month compared to those given dummy pills, the study found.
“You get a bonus with the treatment of statins,” said Dr. Don Poldermans, who led the study at the Erasmus Medical Center in Rotterdam, the Netherlands. The results are in Thursday’s New England Journal of Medicine.
Statins are widely prescribed to reduce cholesterol and prevent heart disease. Doctors wanted to see if statins could also protect against heart problems that are a common complication of blood vessel surgery — operations like repairing a bulging abdominal artery or unclogging arteries in the neck.
The stress of surgery on arteries can destabilize plaque buildup, causing it to rupture and blood clots to form, particularly in heart arteries. Statins are thought to help by reducing inflammation and stabilizing the plaque.
The researchers enrolled nearly 500 patients who were not on statins and were going to have operations on their aorta or leg or neck arteries. For about a month before and a month after their surgery, half the patients took a statin; the rest got a dummy pill.
Within a month of the operation, 12 patients in the statin group, about 5 percent, had died or had heart attacks, compared to 25 patients, or 10 percent, of those who took a dummy pill. Other signs of heart damage also were less common among those who had taken statins. There was no difference in side effects between the two groups.
When the study began in 2004, Poldermans said, statins were not as widely recommended as they are today for people with peripheral artery disease — stiff and narrow arteries, often in the legs. The patients in the study probably weren’t on statins before their surgery because their cholesterol levels were normal or near normal, he said.

“There’s no reason whatsoever to withhold statins anymore” from these patients,” Poldermans said.
Current guidelines recommend the drugs for everyone with peripheral artery disease, regardless of the need for surgery.
The Dutch study was partially funded by Swiss drug maker Novartis, which makes and supplied Lescol, also known as fluvastatin. Poldermans has received grants and consulting fees from Novartis; two other researchers have received fees and grants from medical companies.
Other statins on the market would likely achieve a comparable effect, said Dr. Alan T. Hirsch, director of the vascular medicine program at the Minneapolis Heart Institute and a spokesman for the American Heart Association. He said statins aren’t being used enough in people with peripheral artery disease, and he hopes the study draws attention to their benefits at the time of surgery, as well as throughout the lifetime of the patient.
“A statin is a seat belt when you drive a damaged artery,” he said.